Progyny Inc reports results for the quarter ended December 31 - Earnings Summary

• Progyny Inc PGNY.OQ reported quarterly adjusted earnings of 15 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of 12 cents. The mean expectation of eleven analysts for the quarter was for earnings of 14 cents per share. Wall Street expected results to range from 12 cents to 18 cents per share.

• Revenue rose 6.7% to $313.35 million from a year ago; analysts expected $299.26 million.

• Progyny Inc's reported EPS for the quarter was 15 cents​.

• The company reported quarterly net income of $12.49 million.

• Progyny Inc shares had fallen by 16.9% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 12.6% in the last three months.​

• In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the managed healthcare peer group is also "buy"

• Wall Street's median 12-month price target for Progyny Inc is $30.00, about 28.9% above its last closing price of $21.33

This summary was machine generated from LSEG data February 26 at 10:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)